HOME >> BIOLOGY >> NEWS
Carbon monoxide may help prevent debilitating pregnancy condition

KINGSTON, Ont. -- New findings by Queen's University researchers suggest that administering low doses of carbon monoxide to pregnant women may help prevent the potentially damaging effects to mother and baby of pre-eclampsia.

The study was precipitated by the fact that mothers who smoke cigarettes during pregnancy have a 33 per cent decreased risk of developing pre-eclampsia compared to nonsmokers.

A debilitating condition that affects five to seven per cent of pregnancies, pre-eclampsia is characterized by high blood pressure in pregnant women and is one of the leading causes of baby and maternal deaths. "At present there is no cure or effective treatment for this condition, other than delivery of the baby," says research team leader Dr.Graeme Smith (Obstetrics and Gynecology), an expert in high-risk obstetrics.

In the Queen's study, published in the September issue of the American Journal of Pathology, tissue from the placentas of nonsmoking women who had delivered babies by caesarian section was exposed to the same kind of oxidative stress not enough oxygen being supplied through the blood experienced by women with pre-eclampsia. When the tissues were treated with carbon monoxide, at levels similar to those found in the blood of smoking mothers, cell death in the placenta was significantly reduced.

"We believe that carbon monoxide found in cigarette smoke, and subsequently carried in a smoking mother's blood, may be the cause of their lower risk of developing pre-eclampsia," says Dr. Smith. He stresses however that any perceived benefit of smoking during pregnancy is outweighed by the many risks: premature membrane rupture, preterm delivery, stillbirth, low birth weight, and sudden infant death syndrome.

Produced naturally by the body at low levels, carbon monoxide relaxes blood vessels and may prevent the death of placental cells, which can cause injury to fetus and mother. Future studies will determine w
'"/>

Contact: Nancy Dorrance
dorrance@post.queensu.ca
613-533-2869
Queen's University
5-Sep-2006


Page: 1 2

Related biology news :

1. Tough tubes -- Carbon nanotubes endure heavy wear and tear
2. Carbon dioxide and the ocean
3. Carbon monoxide protects mice from multiple sclerosis
4. Carbon monoxide protects lung cells against oxygen-induced damage
5. On the cutting edge: Carbon nanotube cutlery
6. Carbon capture, water filtration, other boreal forest ecoservices worth estimated $250 billion/year
7. Carbon cycle was already disrupted millions of years ago
8. Carbon monoxide inhibitor controls traumatic bleeding, Tulane University researchers show
9. Carbon nanotube absorption measured in worms, cancer cells
10. Carbon nanotubes that detect disease-causing mutations developed by Pitt researcher
11. Carbon nanoparticles stimulate blood clotting, researchers report

Post Your Comments:
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
(Date:10/16/2014)... on the human body. Battles are won, lost ... cancer, this stalemate—known as tumor dormancy—can last up ... phenomena that is poorly understood. , A ... Salvatore Torquato, a Professor of Chemistry at Princeton ... dormancy and the switch to a malignant state. ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2
(Date:10/22/2014)... , Oct. 22, 2014 New test ... the in vitro diagnostic (IVD) test industry, especially as ... healthcare market researcher listed more than 25 testing innovations ... be the future of IVD products. Kalorama details the new ... The Worldwide Market for In Vitro Diagnostic Tests ...
(Date:10/22/2014)... The North American crystal oscillator market report defines and ... forecast of revenue. This market was valued at $531.4 ... million by 2018, at a CAGR of 3.3% from ... the North American crystal oscillator market report, to get ... provides a glimpse of the segmentation of the market, ...
(Date:10/22/2014)... San Diego, CA (PRWEB) October 22, 2014 ... laboratory balances from Sartorius, A & D Weighing, ... Sartorius CPA Semi-Micro Balance . The Sartorius ... looking for an affordable high-quality, precise, and user-friendly ... in manufacturing of laboratory equipment, their laboratory balances ...
(Date:10/22/2014)... --  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... and diseases, announced today that the U.S. Patent and ... a composition of matter patent application that covers the ... This is Synthetic Biologics, first allowed patent application directly ... the Company,s extensive C. difficile patent estate. ...
Breaking Biology Technology:Report: Radical New IVD Test Approaches Key To Growth 2Report: Radical New IVD Test Approaches Key To Growth 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: